Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorUniversity Medical Center Groningen

About this trial

Rationale: Auditory verbal hallucinations (AVH) - hearing voices that others cannot hear - are common in mental illnesses. For many people AVH are distressing, disabling and persistent, despite medication. Current psychological interventions show low to medium effects. Preliminary studies suggest that an innovative empowering psychological therapy using computer simulations representing the AVH (avatars) can be effective for reducing AVH distress and frequency. Virtual reality (VR) has the potential to improve this treatment. Therefore, we developed a novel VR treatment for this problem. In this study, the effect of this treatment will be investigated.

Objective: To test the effect of a novel VR treatment for AVH (VR-VOICES) on distress and frequency of AVH in patients with a psychiatric disorder. Furthermore, to investigate the effect of VR-VOICES on clinical symptoms, quality of life, and healthcare costs of the treatment.

Eligibility criteria

Qualifiers

Having a DSM-5 diagnosis of a psychiatric disorder

Distressing AVH for minimally 3 months.

Age 16 years or older

Disqualifiers

Insufficient command of the Dutch language

Unable to provide informed consent

Primary diagnosis of a substance use disorder, or organic brain disease (such as dementia)

A degree of substance abuse that hinders treatment adherence

Trial design

Treatments tested in this trial

  • VR-VOICES
  • Treatment as usual

Treatment groups

112 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Medical Center Groningen

Lead sponsor

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborator